The carboxyl terminus of Hsc70-interacting protein (CHIP, also known as STUB1) plays critical roles in the proliferation and differentiation of many types of cells. The potential function of CHIP in tendon-derived stem cells (TDSCs) remains largely unknown at present. Here, we investigated the effects of CHIP on tenogenic differentiation of TDSCs via lentivirus-mediated overexpression. Forced expression of CHIP induced morphological changes and significantly enhanced cell proliferation, as well as tendon differentiation in vitro. Upon stimulation with differentiation induction medium, CHIP-overexpressing TDSCs displayed significant inhibition of differentiation into osteogenic and adipogenic lineages. Subsequent implantation of TDSCs overexpressing CHIP with collagen sponges into nude mice induced a marked increase in ectopic tendon formation in vivo, compared with the control group. Our findings collectively suggest that CHIP is an important contributory factor to tenogenic tissue formation.
Introduction
Tendon injuries are a source of major concern in competitive and recreational athletes, as well as many working conditions requiring repetitive movements [1, 2] . Since tendon repair results in the formation of scar tissue that is biomechanically inferior and prone to lesion recurrence, repair of damaged tendons with conventional treatments have limited potential for regeneration [3] . Tendon tissue engineering offers a promising alternative approach to effectively repair and regenerate injured tendons. Adult stem cells are considered as the ideal source of seed cells for tissue engineering in tendon repair [4] . Many studies have revealed that bone marrow mesenchymal stem cells (BMSCs) or tendon-derived stem cells (TDSCs) can be induced to differentiate into tenocytes and repair injured tendons [5] [6] [7] [8] [9] . However, BMSC implantation may result in ectopic bone and/or cartilage formation within the repair region [10, 11] , and therefore does not present the optimal cell therapy option to restore injured tendons.
Human and mouse tendons have recently been shown to harbor a unique cell population termed TDSCs with universal stem cell characteristics, such as self-renewal, clonogenicity, and multipotency capacity [4, 12, 13] . As stem cells residing in tendons, TDSCs play a critical role in tendon homeostasis and repair by differentiating into tenocytes that are responsible for the maintenance of tendons and repair following injury [14] [15] [16] . Accordingly, these stem cells hold significant promise as a novel cell source for tendon tissue engineering.
The carboxyl terminus of Hsc70-interacting protein (CHIP), also known as STUB1, is a co-chaperone protein and a U-box containing E3 ligase that promotes the ubiquitination and degradation of chaperone-bound proteins [17] . CHIP has been shown to mediate the degradation of epidermal growth factor receptor-2 (HER2 or ErbB2) [18] , SMA and mother against decapentaplegic (MAD)-related proteins (Smads) [19] , runt-related transcription factor 1 (Runx1) [20] , nucleobindin-1 (NUCB1) [21] , receptor-interacting protein kinase 3 (RIPK3) [22] and v-Myc myelocytomatosis viral oncogene homolog (c-Myc) [23] . Recent studies suggest that CHIP negatively regulates osteoblast differentiation and plays critical roles in the regulation of bone mass and bone remodeling, supporting its potential use as a novel therapeutic target in bone loss-associated disorders [24] [25] [26] . However, the exact role of CHIP in tendon differentiation and regeneration remains to be established.
In the current study, we investigated the role of CHIP in TDSC tenogenic differentiation and ectopic tendon formation primarily via lentivirus-mediated CHIP overexpression. Our major finding that CHIP is an important contributory factor to tenogenic tissue formation should aid in improving future TDSC-based cell therapies for tendon injuries.
Materials and Methods

Isolation and culture of rat TDSCs
TDSCs were prepared from 8-week-old Sprague-Dawley male rats as described previously [27] . Briefly, Achilles tendons were digested with collagenase A and dispase for 2.5 h at 37°C. Isolated cells were cultured in Dulbecco's Modified Eagle's Medium (DMEM) plus 10% fetal bovine serum, 1% penicillin-streptomycin, and 2 mM L-glutamine at 37°C in 5% CO 2 . On Day 7, adherent cells were trypsinized and designated as 'Passage 0' cells. Cells from Passages 1-3 were used in the subsequent experiments. All animals were provided by the Animal Center of Capital Medical University (Beijing, China). All animal experiments were approved by the Institutional Animal Care and Use Committee.
Lentivirus infection
The full-length coding region of CHIP was cloned downstream of the cytomegalovirus (CMV) promoter in pCDH plasmid. Non-insert plasmids were used as the negative control. CHIP-expressing or negative control lentiviral plasmid, along with packaging plasmids, was cotransfected into HEK293T cells using Lipofectamine 2000 (Invitrogen, Carlsbad, USA) and lentiviral supernatants were collected 48 h after transfection. TDSCs were infected with the recombinant lentivirus in the presence of 6 μg/ml polybrene (Sigma, St Louis, USA).
RNA extraction and quantitative RT-PCR
Total RNAs were extracted from TDSC-CHIP and TDSCs using TRIzol reagent (Invitrogen) according to the manufacturer's instructions. First-strand cDNA was synthesized using the PrimeScript RT reagent Kit (TaKaRa, Dalian, China). qPCR was performed using SYBR Green PCR Master Mix (Applied Biosystems, Foster City, USA) on an ABI 7500HT System (Applied Biosystems, Carlsbad, USA), with β-actin as the internal control. The primer sequences are listed in Table 1 . Expression levels of genes relative to β-actin mRNA were calculated using the 2 −△△Ct method.
Immunofluorescence staining assay
TDSC-CHIP or TDSCs were fixed with 4% cold paraformaldehyde, permeabilized with 0.2% Triton X-100, and blocked with 2% bovine serum albumin (Invitrogen). Anti-STUB1 (ProteinTech, Wuhan, China), anti-Oct-4 (ProteinTech), anti-Tnmd (Santa Cruz Biotechnology, Santa Cruz, USA) or anti-Scx (Santa Cruz Biotechnology) primary antibodies were applied overnight at 4°C, followed by incubation with the corresponding secondary antibodies for 60 min at 37°C. Nuclei were stained with 4,6-diamidino-2-phenylindole (DAPI; Sigma) 
Cell proliferation and viability assays
Cells were seeded into 96-well plates at a density of 3000 cells/well. After 6 days, the number of viable cells was calculated by direct counting using a hemocytometer in the presence of 0.05% trypan blue. At different time points (Days 2, 4 and 6), cells were treated with 20 μl of 3-[4]-2,5-diphenyl-2,5-tetrazoliumbromide solution (MTT, 5 mg/ml; Sigma) and incubated at 37°C for 4 h. After removal of MTT solution, 150 μl/well DMSO was added. Absorbance was measured at 490 nm using a microplate reader (Thermo Scientific, Waltham, USA).
Cell differentiation assay
Cells were cultured in osteogenic medium (DMEM high glucose, 10% FBS, 10 mM β-glycerophosphate, 50 μM L-ascorbic acid 2-phosphate, 100 nM dexamethasone) or adipogenic medium (DMEM high glucose, 1 μM dexamethasone, 0.2 mM indomethacin, 0.1 mg/ml insulin, and 1 mM 3-isobutyl-1-methylxanthine) for 21 days. The extent of osteogenic or adipogenic differentiation was determined via Alizarin Red and Oil Red O staining, respectively. For the quantification of mineralized matrix deposition, AxioVision LE64 software (Carl Zeiss, Oberkochen, Germany) was used to measure the amount of cellular staining in a given field of view. The percentage of positive area was calculated by dividing the positively stained area by the total [28] . The total number of Oil Red O-positive cells was counted in at least 10 non-overlapping high density fields. The mean differentiation level (%) was expressed as total number of Oil Red O-positive cells divided by total number of cells [29] .
Western blot analysis
Cells were lysed using RIPA buffer (Byotime, Haimen, China). Protein lysates were fractionated via 10% SDS-PAGE (sodium dodecyl sulfate-polyacrylamide gel electrophoresis) and transferred onto polyvinylidene difluoride membrane (Millipore, Bedford, USA). Next, membranes were probed with anti-STUB1 and anti-β-actin antibodies (ProteinTech), followed by horseradish peroxidaseconjugated secondary antibody. Signals were detected via chemiluminescence. β-Actin was used as a protein loading control.
Ectopic implantation and histological examination
TDSCs or TDSC-CHIP (3 × 10 5 cells) were mixed with Type I collagen sponges (3 × 3 × 3 mm 3 , Duragen, Integra Life Sciences, Neu-Ulm, Germany) and ectopically (subcutaneously) implanted into 4-to 8-week-old nude mice. After 30 days of implantation, mice were sacrificed and implants were harvested for histological examination. Explanted tissues were fixed with 4% formalin solution at 4°C overnight. After embedding in paraffin, tissues were cut into 5-μm sections and stained with hematoxylin and eosin (H&E) following routine procedures.
Statistical analysis
Data are expressed as the mean ± standard deviation (SD). Experiments were repeated three times independently using cells from different transfections. The differences between two independent groups were analyzed using two-tailed Student's t-test. P < 0.05 was considered statistically significant.
Results
CHIP is overexpressed in CHIP lentivirus-infected cells
To investigate the role of CHIP in TDSCs, TDSCs were transduced with CHIP-expressing or control lentivirus. As shown in Fig. 1A , qRT-PCR results demonstrated a significant increase in the CHIP mRNA level in CHIP-overexpressing TDSCs (17 folds), compared with control cells. In agreement with the mRNA data, high CHIP protein expression was observed in CHIP-overexpressing TDSCs (Fig. 1B) . Similar results were obtained in immunofluorescence staining assays, which showed strong CHIP protein expression in TDSCs infected with CHIP lentivirus, compared with control lentivirusinfected cells (Fig. 1C) . Our results clearly indicate that CHIP expression is efficiently increased by lentivirus-mediated overexpression.
CHIP overexpression enhances TDSC proliferation and tenogenic differentiation
To examine whether CHIP overexpression affects proliferation, cell viability was analyzed using the MTT assay. Compared with the control group, CHIP overexpression led to significant promotion of TDSC proliferation, as shown in Fig. 2A . CHIP overexpression also increased the number of viable cells compared with the control (Supplementary Fig. S1 ). Next, the effect of upregulated CHIP on tendon differentiation of TDSCs was evaluated. Microscopic examination of cell morphology revealed that TDSCs with induced CHIP expression exhibited an elongated shape similar to that of tenocytes in culture (Fig. 2B) . Immunofluorescence staining for the stem cell marker, Oct-4, revealed a lower number of Oct-4-positive cells in the CHIP overexpression versus control group, indicative of decreased stemness of CHIP-containing TDSCs (Fig. 2B) . Similar results were obtained in western blot analysis ( Supplementary Fig. S2 ). Moreover, overexpression of CHIP resulted in a marked increase in the expression of tenocyte-related mRNAs (Tnmd, Scx, Col I, Col III, and Decorin), compared with the control group (Fig. 2C) . Consistently, At 72 h after infection, CHIP mRNA and protein levels were measured by qRT-PCR (A), western blot analysis (B), and immunofluorescence staining (×200) (C). Nuclei were stained with DAPI (blue). Data are expressed as the mean ± SD (n = 3). *P < 0.05.
protein levels of Tnmd and Scx were also increased in the presence of CHIP (Fig. 2D, Supplementary Fig. S2 ). Our data collectively indicate that CHIP promotes the proliferation and tenogenic differentiation of TDSCs.
CHIP overexpression leads to inhibition of TDSC differentiation into osteogenic and adipogenic lineages
The role of CHIP in multilineage differentiation of TDSCs was also investigated. As shown in Fig. 3A , after osteogenic induction, mRNA levels of the osteogenic markers, Runx2, alkaline phosphatase (ALP), and Osteocalcin, were significantly reduced in CHIPoverexpressing TDSCs, compared with control cells. Alizarin Red staining additionally showed lower osteogenesis in the CHIP overexpression group relative to the control group (Fig. 3B , and Supplementary Fig. S3A) . Furthermore, expression analysis of the adipogenic markers, peroxisome proliferator-activated receptor-γ (PPARγ), adipocyte protein 2 (AP2), and Adiponectin, revealed the significant downregulation in CHIP-overexpressing TDSCs (Fig. 3C) . Oil Red O staining confirmed that CHIP overexpression significantly inhibited lipid vacuole formation, compared with the control group, after adipogenic induction (Fig. 3D, Supplementary Fig. S3B ). Based on these findings, we conclude that CHIP inhibits osteogenic and adipogenic differentiation of TDSCs.
CHIP overexpression enhances tendon-like tissue formation in vivo
The role of CHIP in tendon-like tissue formation in vivo was further investigated. TDSCs or CHIP-overexpressing TDSCs were mixed with Type I collagen sponges and ectopically (subcutaneously) implanted into nude mice. Thirty days after implantation, mice were sacrificed, and implants were explanted and subjected to H&E staining. As shown in Fig. 4A , compared with the control group, overexpression of CHIP significantly promoted the formation of fibroblastic tendon-like tissue with a characteristic wavy crimp pattern. Consistent with this finding, qRT-PCR analysis demonstrated increased transcript levels of Scx and Tnmd genes in CHIP-producing versus control construct groups (Fig. 4B) . Clearly, CHIP overexpression in TDSCs enhances the formation of tendon-like tissues.
Discussion
Stem cell-based cell therapy is considered to have significant potential in improving the repair of tendon injuries, which affect millions of people in the USA each year [30] . As tendon-specific stem cells, TDSCs may be an optimal cell source for tendon tissue engineering. Effective use of TDSCs relies on a better understanding of the underlying mechanisms of tendon development. Previous reports suggested that primary cultures derived from healthy or ruptured tendons show significant differences [31, 32] . In this study, TDSCs were explanted from healthy rat Achilles tendons. This is the first time to demonstrate that CHIP, a U-box containing E3 ubiquitin ligase, plays a critical role in tendon differentiation and regeneration of TDSCs.
Various molecules are involved in tenogenic differentiation of stem cells. For example, SMAD family member 8 (Smad8) mediates the differentiation of mesenchymal stem cells (MSCs) into tendonlike cells. Genetically modified MSCs that overexpress Smad8 and bone morphogenetic protein 2 (BMP2) are capable of inducing tendonregeneration in the Achilles tendon model [33] . Forced early growth response-1 (EGR1) expression programs MSCs toward tendon lineage and promotes the formation of in vitro-engineered tendons. Application of EGR1-producing MSCs has been shown to increase the formation of tendon-like tissues in a rat model of Achilles tendon injury [34] . Scx and Tnmd are two key molecules involved in the process of tendon development. Overexpression of Scx or Tnmd promotes tenocytic differentiation through suppressing the non-tenogenic potential of MSCs in vitro and enhances neotendon tissue formation in vivo [35, 36] . In the current experiments, we found that CHIP overexpression promoted TDSC tenogenic differentiation through enhancement of the expressions of tenocyte-related gene (Tnmd, Scx, Col I, Col III, and Decorin) and alterations in cell morphology and stemness. It has been reported that suppression of OCT4 is correlated with cell-fate specification and lineage-specific differentiation [37] . Here, TDSCs overexpressing CHIP showed reduced expression of Oct-4 protein, compared with TDSCs. In addition, forced CHIP expression also inhibited TDSC differentiation into osteogenic and adipogenic lineages. Following implantation of CHIPoverexpressing TDSCs with collagen sponges into nude mice, we observed a remarkable increase in ectopic tendon formation in vivo, compared with that in the control group.
The E3 ubiquitin-protein ligase CHIP/STUB1 plays different roles in several diseases. Decreased expression of CHIP leads to increased angiogenesis and poor prognosis in human renal cell carcinoma [38] . CHIP-deficient mice exhibit inflammation in the thymus and massive cell death and disintegration in the small intestinal tract, resulting in death within a few weeks after birth [22] . In addition, CHIP expression is gradually decreased during osteoblast differentiation [25] . Negative regulation of the Runx2 protein by CHIP is critical in the commitment of precursor cells to differentiate into the osteoblast lineage [26] . However, the role of CHIP in tendon injuries has not been explored. In the present study, we investigated the effects of CHIP on TDSC tenogenic differentiation and ectopic tendon formation via lentivirus-mediated CHIP overexpression. Our results clearly demonstrate that TDSCs overexpressing CHIP promote tendon differentiation in vitro and ectopic tendon formation in vivo, supporting its potential use as a putative therapeutic target in tendon repair strategies. Based on this finding, further studies are needed to examine patient-derived TDSCs and to determine whether CHIP overexpression also promotes tendon formation in humans. . CHIP overexpression enhances tendon-like tissue formation in vivo Modified TDSCs were applied on a collagen sponge and ectopically (subcutaneously) implanted into nude mice. Thirty days after implantation, mice were sacrificed, and implants were explanted and subjected to H&E staining. Representative images are shown in (A), Scale bar: 100 μm. (B) qRT-PCR analysis of transcript levels of Scx and Tnmd in tendon-like constructs. Data are expressed as the mean ± SD (n = 3). *P < 0.05.
In summary, our results provide novel insights into the role of CHIP in tendon physiology/pathology, showing that CHIP contributes to tendon formation by enhancing TDSC tenogenic differentiation. The molecular interactions between CHIP and its binding proteins underlying tendon formation require investigation in future studies.
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